GUMC Update - The online newsletter of the Georgetown University Medical Center Community

GUMC Update is the electronic newsletter for the Georgetown University Medical Center community. Please let us know what you think.

To view previous issues of GUMC Update, visit the Update Archive.
More online news >

With the help of the expertise of Kathryn Sandberg, PhD, the National Institutes of Health is poised to implement reforms to address the underrepresentation of female cells and animals in preclinical research.

Read More >

Ranit Mishori, MD, MHS, participated in the Global Summit to End Sexual Violence in Conflict, held last week in London. She moderated a panel focused on the role of technology in securing forensic medical evidence in conflict situations to increase accountability.

Read More >




Members of the community came together with scientists at a recent event at the Swiss Ambassador's Residence to celebrate the successes of Partners in Research, a novel philanthropic program that empowers donors to vote on the projects they wish to fund.

Read More >

Valerie Darcey, a doctoral student in Georgetown's Interdisciplinary Program in Neuroscience, is one of 19 student researchers from the U.S. chosen to attend the 64th Annual Lindau Nobel Laureate Meeting in Lindau, Germany, from June 29 to July 4. 

Read More >



Laura Anderko, PhD, RN, the Robert and Kathleen Scanlon Chair in Values Based Health Care at the School of Nursing & Health Studies, won a 2014 Nursing Excellence GEM Award at a recent ceremony.

Read More >



Dr. Louis Weiner participated in a twitter chat titled "The Promise of Immunotherapy," hosted by the American Association for Cancer Research and moderated by Time magazine's senior health reporter Alice Park (#CIMChat). 


The Washington Post focused on a Georgetown study about the prevention or delay of Alzheimer's disease. Dr. Scott Turner, Dr. James Giordano and a patient were interviewed for the story.


Dr. Scott Turner participated in a live interview with NBC4 about an Alzheimer's study to prevent/delay onset of disease.


Dr. Paul Roepe was interviewed by the Associated Press about the accidental exposure of CDC scientists to anthrax. 


Dr. Ranit Mishori was interviewed by Thompson Reuters Foundation about a Physicians for Human Rights app being developed for documenting evidence of rape in areas of conflict.


Dr. Kenneth Lin was interviewed by US News & World Report for an article about the overuse of antibiotics.


AARP's The Magazine interviewed Dr. Maral Skelsey about skin cancer risks.


HealthDay carried a story about Dr. Vanessa Sheppard's research on older breast cancer patients and uptake of hormone therapy.  The story was carried by US News & World Report and YahooHealth.


Medscape interviewed Dr. Vanessa Sheppard about the importance of exercise after surviving breast cancer.


The Cancer Letter carried an announcement about Dr. Michael Atkins' leadership of the Regional Immunotherapy Discovery Program assembled with Hackensack University Medical Center faculty (available upon request). 



President Obama has announced the appointment of Georgetown Provost Robert M. Groves to a six-year term on the prestigious National Science Foundation's National Science Board. 

A recent study has shown that most women over 65 with non-metastatic breast cancer complied with their oncologists' recommendations to treat their estrogen-positive breast cancer with hormone therapy - either an aromatase inhibitor or tamoxifen. These drugs prevent tumors from using estrogen to fuel growth.

The Huntington Disease Care, Education and Research Center at MedStar Georgetown University Hospital, in collaboration with GUMC, is studying a new therapy to manage uncontrollable movements experienced by patients with HD.

Investigators from Georgetown Lombardi say adding anti-malarial drug hydroxychloroquine to tamoxifen could provide a new treatment option for some women with advanced, postmenopausal estrogen receptor-positive breast cancer.

GUMC researchers have launched a clinical study aimed at preventing or delaying Alzheimer's disease in people who don't have symptoms but already have the tell-tale signs in their brains.

Up to 40 percent of lung cancer patients do not respond to a targeted therapy designed to block tumor growth. Now, scientists at Georgetown Lombardi and the National Cancer Institute have discovered why that intrinsic resistance occurs - and they pinpoint a drug they say could potentially reverse it. 

More events >
Wednesday, June 25, 10:00 a.m.-12:00 p.m.
St. Mary's Hall, Room 414
Mentor Training for Clinical & Translational Researchers Workshop
Thursday, July 3
Pre-Clinical Science Building, GE 4, 6, 8
Monday, June 30, 1:00-6:00 p.m.
Raspberry Falls Golf Club  

Monday, August 11, to Friday, August 15

MedStar Health Research Institute

Summer Intensive Workshop: Biostatistics, Epidemiology and Clinical Research 


To view previous issues of GUMC Update, visit the Update Archive.

 School of Nursing & Health Studies
Copyright Georgetown University 2014
About the Update | | Contact Us